Up­dat­ed: Sam­sara backs ex-Gilead duo's amal­ga­ma­tion of NASH, liv­er drug as­sets from for­mer em­ploy­er, oth­er bio­phar­mas

A new biotech just dropped with a bas­ket of as­sets, in­clud­ing two clin­i­cal-stage ones, from Gilead, Sh­iono­gi, Phenex Phar­ma­ceu­ti­cals, Astel­las’ Mi­to­bridge and Yale.

The Pa­lo …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER